Perrigo Company plc Acquisitions, Net of Cash Acquired
Perrigo Company plc (PRGO) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2025-02-28
- Perrigo Company plc payments to acquire businesses, net of cash acquired for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Perrigo Company plc payments to acquire businesses, net of cash acquired for the quarter ending 2023-09-30 was $0.00.
- Perrigo Company plc payments to acquire businesses, net of cash acquired for the quarter ending 2022-12-31 was $110.00M.
- Perrigo Company plc payments to acquire businesses, net of cash acquired for the quarter ending 2022-10-01 was $0.00.
- Perrigo Company plc payments to acquire businesses, net of cash acquired for fiscal 2024 was $0.00.
- Perrigo Company plc payments to acquire businesses, net of cash acquired for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Perrigo Company plc payments to acquire businesses, net of cash acquired for fiscal 2022 was $2.01B.
- Perrigo Company plc payments to acquire businesses, net of cash acquired for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 12 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-28 | |||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 10-K · filed 2025-02-28 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | ||||
| 2023-07-01 | $0.00 10-Q · filed 2023-08-08 | |||||
| 2022-12-31 | $110.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $110.00M derived: sum of 2 quarters · filed 2025-02-28 | $2.01B 10-K · filed 2025-02-28 | |||
| 2022-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $1.90B 10-Q · filed 2023-11-07 | ||||
| 2022-07-02 | $1.90B 10-Q · filed 2023-08-08 | |||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 | ||
| 2021-10-02 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | $62.50M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-07-03 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $62.50M derived: sum of 3 quarters · filed 2023-02-28 | $62.50M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-04-03 | $0.00 10-Q · filed 2021-05-12 | $62.50M derived: sum of 2 quarters · filed 2023-02-28 | $62.50M derived: sum of 3 quarters · filed 2023-02-28 | $157.20M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $62.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $62.50M derived: sum of 2 quarters · filed 2023-02-28 | $157.20M derived: sum of 3 quarters · filed 2023-02-28 | $168.50M 10-K · filed 2023-02-28 | ||
| 2020-09-26 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $94.70M derived: sum of 2 quarters · filed 2021-11-12 | $106.00M 10-Q · filed 2021-11-12 | $104.20M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-27 | $94.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $106.00M 10-Q · filed 2021-08-11 | $104.20M derived: sum of 3 quarters · filed 2022-03-01 | $853.70M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-28 | $11.30M 10-Q · filed 2021-05-12 | $9.50M derived: sum of 2 quarters · filed 2022-03-01 | $759.00M derived: sum of 3 quarters · filed 2022-03-01 | $759.00M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | -$1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $747.70M derived: sum of 2 quarters · filed 2022-03-01 | $747.70M derived: sum of 3 quarters · filed 2022-03-01 | $747.70M 10-K · filed 2022-03-01 | ||
| 2019-09-28 | $749.50M 10-Q · filed 2019-11-06 | $749.50M derived: sum of 2 quarters · filed 2020-08-05 | $749.50M 10-Q · filed 2020-11-05 | |||
| 2019-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $0.00 10-Q · filed 2020-08-05 | ||||
| 2019-03-30 | $0.00 10-Q · filed 2020-05-05 | |||||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 | |||||
| 2017-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $400.00K derived: sum of 2 quarters · filed 2020-02-27 | $400.00K derived: sum of 3 quarters · filed 2020-02-27 | $400.00K 10-K · filed 2020-02-27 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | -$9.40M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-07-01 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $0.00 10-Q · filed 2017-08-10 | -$9.40M derived: sum of 3 quarters · filed 2019-02-27 | $7.70M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-04-01 | $0.00 10-Q · filed 2017-05-30 | -$9.40M derived: sum of 2 quarters · filed 2019-02-27 | $7.70M derived: sum of 3 quarters · filed 2019-02-27 | $11.00M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2016-12-31 | -$9.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $7.70M derived: sum of 2 quarters · filed 2019-02-27 | $11.00M derived: sum of 3 quarters · filed 2019-02-27 | $427.40M 10-K · filed 2019-02-27 | ||
| 2016-10-01 | $17.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $20.40M derived: sum of 2 quarters · filed 2017-11-09 | $436.80M 10-Q · filed 2017-11-09 | $432.10M 10-Q · filed 2016-11-10 | $823.30M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-07-02 | $3.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $419.70M 10-Q · filed 2017-08-10 | $806.20M derived: sum of 3 quarters · filed 2018-03-01 | $1.21B derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-04-02 | $416.40M 10-Q · filed 2017-05-30 | $802.90M derived: sum of 2 quarters · filed 2018-03-01 | $1.21B derived: sum of 3 quarters · filed 2018-03-01 | $3.30B derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-12-31 | $386.50M derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-01 | $791.60M 10-K · filed 2018-03-01 | $2.89B derived: sum of 3 quarters · filed 2018-03-01 | $2.89B derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-09-26 | $405.10M 10-Q · filed 2015-11-02 | $2.50B derived: sum of 2 quarters · filed 2017-05-22 | $2.50B 10-Q/A · filed 2017-05-23 | $2.59B derived: sum of 4 quarters · filed 2017-05-22 | ||
| 2015-06-27 | $2.09B derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22 | $2.10B 10-Q/A · filed 2017-05-22 | $2.18B derived: sum of 3 quarters · filed 2017-05-22 | $2.18B 10-K · filed 2018-03-01 | $2.18B 10-K · filed 2015-08-13 | |
| 2015-03-28 | $4.00M 10-Q/A · filed 2017-05-22 | $87.00M derived: sum of 2 quarters · filed 2017-05-22 | $87.00M 10-Q · filed 2015-04-29 | $94.50M derived: sum of 4 quarters · filed 2017-05-22 | ||
| 2014-12-27 | $83.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | $83.00M 10-Q · filed 2015-02-05 | $90.50M derived: sum of 3 quarters · filed 2017-05-22 | $160.90M derived: sum of 4 quarters · filed 2017-05-22 | ||
| 2014-09-27 | $0.00 10-Q · filed 2015-11-02 | $7.50M derived: sum of 2 quarters · filed 2017-05-22 | $77.90M derived: sum of 3 quarters · filed 2017-05-22 | |||
| 2014-06-28 | $7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22 | $77.90M derived: sum of 2 quarters · filed 2017-05-22 | $1.61B 10-K · filed 2017-05-22 | |||
| 2014-03-29 | $70.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29 | $1.60B 10-Q · filed 2015-04-29 | ||||
| 2013-12-28 | $1.53B 10-Q · filed 2015-02-05 | |||||
| 2013-06-29 | $244.50M derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25 | $525.40M derived: sum of 2 quarters · filed 2016-02-25 | $852.30M 10-KT · filed 2016-02-25 | |||
| 2013-03-30 | $280.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | $607.80M 10-Q · filed 2014-05-07 | ||||
| 2012-12-29 | $326.90M 10-Q · filed 2014-02-06 | |||||
| 2012-06-30 | $582.30M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |